In Vivo: 37 (5)

September-October 2023; Volume 37,Issue 5

Reviews

Open Access
Pathogenesis of Endometriosis: Focus on Adenogenesis-related Factors
PIETRO G. SIGNORILE, ALFONSO BALDI, ROSA VICECONTE, ANDREA RONCHI and MARCO MONTELLA

In Vivo September 2023, 37 (5) 1922-1930; DOI: https://doi.org/10.21873/invivo.13288
Open Access
Pectoralis Major Muscle Morbidity After Submuscular Silicone-based Breast Reconstruction: A Systematic Review
ANGELIKI STAMOULI, SOPHOCLES LANITIS and MICHAEL KONTOS

In Vivo September 2023, 37 (5) 1931-1939; DOI: https://doi.org/10.21873/invivo.13289

Experimental Studies

Open Access
Therapeutic Efficacy of Temsirolimus in a Patient-derived Model of Metastatic Fibrolamellar Hepatocellular Carcinoma
JENNIFER L. LEITING, MATTHEW C. HERNANDEZ, JOHN R. BERGQUIST, JENNIFER A. YONKUS, AMRO M. ABDELRAHMAN, MICHAEL S. TORBENSON, NGUYEN H. TRAN, THORVARDUR R. HALFDANARSON, RONDELL P. GRAHAM, RORY L. SMOOT and MARK J. TRUTY

In Vivo September 2023, 37 (5) 1940-1950; DOI: https://doi.org/10.21873/invivo.13290
Open Access
In Vitro Carbon Ion Beam and Gemcitabine Chemoradiation in a Mucoepidermoid Carcinoma Cell Line
THOMAS SCHNEIDER, FELIX ZWICKER, PETER ERNST HUBER, JÜRGEN DEBUS and HENRIK HAUSWALD

In Vivo September 2023, 37 (5) 1951-1959; DOI: https://doi.org/10.21873/invivo.13291
Open Access
Renieramycin T Derivative DH_22 Induces p53-dependent Apoptosis in Lung Cancer Cells
INDIANA GITA ANGGRAENI, ZIN ZIN EI, DAIKI HOTTA, MASASHI YOKOYA and PITHI CHANVORACHOTE

In Vivo September 2023, 37 (5) 1960-1966; DOI: https://doi.org/10.21873/invivo.13292
Open Access
Active-phase Plasma Alkaline Phosphatase Isozyme Activity Is a Sensitive Biomarker for Excessive Fructose Intake
YUSUKE SUZUKI, DAIGO YOKOYAMA, CHIZURU MATSUURA, KAZUMA KONDO, TAISHI SHIMAZAKI, KATSUNORI RYOKE, AKIO KOBAYASHI and HIROYUKI SAKAKIBARA

In Vivo September 2023, 37 (5) 1967-1974; DOI: https://doi.org/10.21873/invivo.13293
Open Access
Determination of the Possible Target Genes of Hepatoma-derived Growth Factor in Hepatoma Cells
HIRAYUKI ENOMOTO, TAKASHI NISHIMURA, SHINYA FUKUNUSHI, HIDEYUKI SHIOMI and HIROKO IIJIMA

In Vivo September 2023, 37 (5) 1975-1979; DOI: https://doi.org/10.21873/invivo.13294
Open Access
Role of Mir-452-5p Overexpression in Epithelial–Mesenchymal Transition (EMT) in Early-stage Colorectal Cancer
YUKIKO KOYAMA, SHINTARO FUJIHARA, TAIGA CHIYO, TAKANORI MATSUI, SAE HAMAYA, KOJI FUJITA, JOJI TANI, ASAHIRO MORISHITA, HIDEKI KOBARA, MASAFUMI ONO, HISAKAZU IWAMA and TSUTOMU MASAKI

In Vivo September 2023, 37 (5) 1980-1990; DOI: https://doi.org/10.21873/invivo.13295
Open Access
Humanized PD-1 Knock-in Mice Reveal Nivolumab’s Inhibitory Effects on Glioblastoma Tumor Progression In Vivo
CHUN-YU CHIANG, MENG-CHU HUANG, SHIH-CHONG TSAI, FEI-TING HSU, TSAI-LAN LIAO, JEI-HWA YU, TZU-HSIANG LIN, HUA-HSIH HUANG and PEN-AN LIAO

In Vivo September 2023, 37 (5) 1991-2000; DOI: https://doi.org/10.21873/invivo.13296
Open Access
Effects of Chitosan on Chondrocytes Derived from Human Nasal Septal Cartilage
YU-HSUN CHIU, I-CHENG CHEN, TZU-HAN LIN, TAI-HORNG YOUNG and HSU-WEI FANG

In Vivo September 2023, 37 (5) 2001-2005; DOI: https://doi.org/10.21873/invivo.13297
Open Access
The Role of Box A of HMGB1 in Enhancing Stem Cell Properties of Human Mesenchymal Cells: A Novel Approach for the Pursuit of Anti-aging Therapy
ZIN ZIN EI, APIWAT MUTIRANGURA, WANATCHAPORN ARUNMANEE and PITHI CHANVORACHOTE

In Vivo September 2023, 37 (5) 2006-2017; DOI: https://doi.org/10.21873/invivo.13298
Open Access
Using Treg, Tr1, and Breg Expression Levels to Predict Clinical Responses to csDMARD Treatment in Drug-naive Patients With Rheumatoid Arthritis
TING-YU HSIEH, SHAN-WEN LUI, JENG-WEI LU, YEN-CHEN CHEN, TING-CHUN LIN, WUN-LONG JHENG, YI-JUNG HO and FENG-CHENG LIU

In Vivo September 2023, 37 (5) 2018-2027; DOI: https://doi.org/10.21873/invivo.13299
Open Access
Therapeutic Effect of Human Adipocyte-derived Stem Cell-derived Exosomes on a Transgenic Mouse Model of Parkinson’s Disease
LUNG CHAN, WAYNE HSU, KAI-YUN CHEN, WEU WANG, YI-CHIEH HUNG and CHIEN-TAI HONG

In Vivo September 2023, 37 (5) 2028-2038; DOI: https://doi.org/10.21873/invivo.13300
Open Access
Orthotopic Mouse Models of Urinary Bladder Cancer
JI-IN NOH, EUN-JUNG AHN, MYUNG-GIUN NOH, KYUNG-SUB MOON, EUIHEON CHUNG, CHAN CHOI, KYUNG-HWA LEE and SUNG SUN KIM

In Vivo September 2023, 37 (5) 2039-2043; DOI: https://doi.org/10.21873/invivo.13301
Open Access
Toll-like Receptor Agonist CBLB502 Protects Against Cisplatin-induced Liver and Kidney Damage in Mice
PENGZHEN NIU, WENYU ZHAO, QIONG WANG, JUNZHAO DUAN, JIE ZHU, HANJIANG FU, YONGGE WU, XIAOFEI ZHENG, DAGUANG ZHANG and CHANGHUI GE

In Vivo September 2023, 37 (5) 2044-2056; DOI: https://doi.org/10.21873/invivo.13302
Open Access
Effects of the Foam Massage Roller on VEGF-A and FGF-2 Blood Levels in Young Men
ADAM ROSLANOWSKI, ALEKSANDRA PARTYNSKA, KATARZYNA RATAJCZAK-WIELGOMAS, ALICJA KMIECIK, JEDRZEJ GRZEGRZOLKA, PIOTR DZIEGIEL, ADAM JANUSZKO, DARIUSZ LENART and WALDEMAR ANDRZEJEWSKI

In Vivo September 2023, 37 (5) 2057-2069; DOI: https://doi.org/10.21873/invivo.13303
Open Access
Expression of Apurinic/Apyrimidinic Endonuclease 1 in Colorectal Cancer and its Relation to Tumor Progression and Prognosis
JI-YUN HONG, HYUNG-HOON OH, SUN-YOUNG PARK, YOUNG-LAN PARK, SUNG-BUM CHO and YOUNG-EUN JOO

In Vivo September 2023, 37 (5) 2070-2077; DOI: https://doi.org/10.21873/invivo.13304
Open Access
Investigating the Anti-Aging Effects of Caviar Oil on Human Skin
LINH THI THUY LE, BAEK-KYU KIM, PHAM NGOC CHIEN, KEON-WOO CHOI, HONG-BIN KIM, UI-JAE HWANG, HYO SUN HAN and CHAN-YEONG HEO

In Vivo September 2023, 37 (5) 2078-2091; DOI: https://doi.org/10.21873/invivo.13305
Open Access
Intensity-dependent Temperature Rise Induced by Local Exposure to 26.5 GHz Quasi-Millimeter-Wave in Rat
ETSUKO IJIMA, KUN LI, TAKASHI HIKAGE, AKIKO NAGAI, YASUTAKA MURAKAMI, TAKUJI ARIMA, TATSUYA ISHITAKE and HIROSHI MASUDA

In Vivo September 2023, 37 (5) 2092-2099; DOI: https://doi.org/10.21873/invivo.13306
Open Access
Acupuncture Treatment Improves Transport Stress in Microminipigs Through the Acupoint in Ears
MOE IJIRI, KOHEI AKIOKA, TAISUKE KITANO, HIROSHI MIURA, HISAYA K. ONO, RYOTA TERASHIMA, YOSHIKAZU FUJIMOTO, TOMOHIDE MATSUO, OSAMU YAMATO and HIROAKI KAWAGUCHI

In Vivo September 2023, 37 (5) 2100-2104; DOI: https://doi.org/10.21873/invivo.13307
Open Access
Comparing the Influences of Metformin and Berberine on the Intestinal Microbiota of Rats With Nonalcoholic Steatohepatitis
DONGYA CHEN, JINGFANG XIONG, GAOFENG CHEN, ZHAOLIN ZHANG, YIHUI LIU, JIANJUN XU and HONG XU

In Vivo September 2023, 37 (5) 2105-2127; DOI: https://doi.org/10.21873/invivo.13308
Open Access
A Preliminary Study of Pharmacokinetics and Pharmacodynamics of Oral Fingolimod in Dogs
TAESIK YUN, JONG-WOO JEONG, YOONHOI KOO, YEON CHAE, DOHEE LEE, HAKHYUN KIM, SOOCHONG KIM, MHAN-PYO YANG, KYEONG-RYOON LEE and BYEONG-TECK KANG

In Vivo September 2023, 37 (5) 2128-2133; DOI: https://doi.org/10.21873/invivo.13309

Clinical Studies

Open Access
Rapid Reduction of CEA and Stable Metastasis in an NRAS-mutant Rectal-Cancer Patient Treated With FOLFIRI and Bevacizumab Combined With Oral Recombinant Methioninase and a Low-Methionine Diet Upon Metastatic Recurrence After FOLFIRI and Bevacizumab Treatment Alone
YUTARO KUBOTA, QINGHONG HAN, SEI MORINAGA, TAKUYA TSUNODA and ROBERT M. HOFFMAN

In Vivo September 2023, 37 (5) 2134-2138; DOI: https://doi.org/10.21873/invivo.13310
Open Access
Baseline Troponin Level and Cardiac Toxicity in HER2-positive Early Breast Cancer Patients Receiving Trastuzumab
MARIA LAURA CANALE, GIANCARLO CASOLO, SARA DONATI, IRMA BISCEGLIA, CHETI PUCCETTI, DOMENICO AMOROSO, ELIO VENTURINI, NICOLA MAUREA, FABIO MARIA TURAZZA and ANDREA CAMERINI

In Vivo September 2023, 37 (5) 2139-2146; DOI: https://doi.org/10.21873/invivo.13311
Open Access
Utility of Precision Oncology Using Cancer Genomic Profiling for Head and Neck Malignancies
MIOKO MATSUO, KAZUKI HASHIMOTO, RYUNOSUKE KOGO, RINA JIROMARU, TAKAHIRO HONGO, TOMOMI MANAKO and TAKASHI NAKAGAWA

In Vivo September 2023, 37 (5) 2147-2154; DOI: https://doi.org/10.21873/invivo.13312
Open Access
A Prospective Study of AFree Oral Spray as an Adjuvant Therapy for Mild and Moderate COVID-19 in Community Health Stations: Clinical Progression and Viral Clearance Outcomes
DUONG T. TRAN, TRUONG N. PHAM, NHUNG HT NGUYEN, HAU D. TRAN, HUY Q. HOANG, BO HAN and BA X. HOANG

In Vivo September 2023, 37 (5) 2155-2160; DOI: https://doi.org/10.21873/invivo.13313
Open Access
Detection of 14 High-risk Human Papillomavirus (HPV) Genotypes Within the Italian Cervical Cancer Screening
MARIA CENCI, FRANCESCA ROSSI and TIZIANA PISANI

In Vivo September 2023, 37 (5) 2161-2165; DOI: https://doi.org/10.21873/invivo.13314
Open Access
Complication of Gastric Cancer Surgery: A Single Centre Experience
MARTA GOGLIA, SARA PEPE, MARCO PACE, LUDOVICA FATTORI, ANDREA MINERVINI, DIEGO GIULITTI, DARIO SIRIMARCO, GAETANO GALLO, GIUSEPPE NIGRI, GIOVANNI RAMACCIATO and PAOLO AURELLO

In Vivo September 2023, 37 (5) 2166-2172; DOI: https://doi.org/10.21873/invivo.13315
Open Access
Comparison of Distress Scores Before and After Radiotherapy for Prostate Cancer
STEFAN JANSSEN, CANSU DELIKANLI, NATHAN Y. YU and DIRK RADES

In Vivo September 2023, 37 (5) 2173-2177; DOI: https://doi.org/10.21873/invivo.13316
Open Access
Comparison of Functional and Morphological Estimates of Vascular Age
MARTIN SIGL, LAURA WINTER, GERHARD SCHUMACHER, STEFANIE CHRISTINA HELMKE, TETYANA SHCHETYNSKA-MARINOVA, KLAUS AMENDT, DANIEL DUERSCHMIED and ANNA LENA HOHNECK

In Vivo September 2023, 37 (5) 2178-2187; DOI: https://doi.org/10.21873/invivo.13317
Open Access
Pembrolizumab Monotherapy Versus Pembrolizumab Plus Chemotherapy in Patients With Head and Neck Squamous Cell Carcinoma
MIOKO MATSUO, MUNEYUKI MASUDA, MORIYASU YAMAUCHI, MASAHIKO TAURA, KAZUKI HASHIMOTO, RYUNOSUKE KOGO, RINA JIROMARU, TAKAHIRO HONGO, TOMOMI MANAKO and TAKASHI NAKAGAWA

In Vivo September 2023, 37 (5) 2188-2196; DOI: https://doi.org/10.21873/invivo.13318
Open Access
Effect of the Minimum Inhibitory Concentration of Vancomycin on the Clinical Outcome of Enterococcus faecium Bacteremia
TAKANOBU HOSHI, KEI WATANABE, YUTA FUKUMURA, KOJI MIYAZAKI, MADOKA TAKAHASHI, SAKAE TANIGUCHI, NAOKI WADA, MIKA MIURA, SHOYA KATO, KAZUNORI YAMADA, SATOSHI FUJII and HIDEKI SATO

In Vivo September 2023, 37 (5) 2197-2202; DOI: https://doi.org/10.21873/invivo.13319
Open Access
Atezolizumab Monotherapy for Non-small Cell Lung Cancer Patients: An Observational Study in Ibaraki Group (ATTENTION-IBARAKI)
SHINICHIRO OKAUCHI, GEN OHARA, TOSHIHIRO SHIOZAWA, HIROKO WATANABE, TAKESHI NUMATA, RYOTA NAKAMURA, TOMOHIRO TAMURA, NORIHIRO KIKUCHI, KUNIHIKO MIYAZAKI, SHIGEN HAYASHI, HIROFUMI SAKURAI, TAKAAKI YAMASHITA, KOICHI KURISHIMA, MASAHARU INAGAKI, TAKEO ENDO, HIROICHI ISHIKAWA, TAKAYUKI KABURAGI, HIROAKI SATOH, TORU SAKAMOTO and NOBUYUKI HIZAWA

In Vivo September 2023, 37 (5) 2203-2209; DOI: https://doi.org/10.21873/invivo.13320
Open Access
Importance of the Number and Location of Lymph Node Metastasis in Oropharyngeal Cancer
MASATO IIDA, TARO MURAI, MAYU KUNO, KENSHIRO OSUMI, MIKIKO NAKANISHI-IMAI, DAI OKAZAKI, TAKAYUKI MURASE, DAISUKE KAWAKITA, SHINICHI IWASAKI, HIROSHI INAGAKI, NATSUO TOMITA, YUTA SHIBAMOTO and AKIO HIWATASHI

In Vivo September 2023, 37 (5) 2210-2218; DOI: https://doi.org/10.21873/invivo.13321
Open Access
Is There an Association Between Circulating Kisspeptin Levels and Ovarian Reserve in Women of Reproductive Age?
KONSTANTINOS NIKOLETTOS, NIKOLAOS VLAHOS, OLGA PAGONOPOULOU, NIKOS NIKOLETTOS, KONSTANTINOS ZIKOPOULOS, PANAGIOTIS TSIKOURAS, EMMANOUIL KONTOMANOLIS, CHRISTOS DAMASKOS, NIKOLAOS GARMPIS and BYRON ASIMAKOPOULOS

In Vivo September 2023, 37 (5) 2219-2223; DOI: https://doi.org/10.21873/invivo.13322
Open Access
Cetuximab Plus Concurrent Radiotherapy in Patients With Nasopharyngeal Carcinoma
MORIYASU YAMAUCHI, YUKI SATO, TOMOYA ISHIDA, AKIMICHI MINESAKI, ERIKO SHIMAZAKI and YUICHIRO KURATOMI

In Vivo September 2023, 37 (5) 2224-2228; DOI: https://doi.org/10.21873/invivo.13323
Open Access
Serious Immune-related Adverse Events Are Associated With Greater Efficacy of Nivolumab Therapy Against Non-small Cell Lung Cancer
JIRI BLAZEK, PETR HOSEK, KAROLINA HRABCOVA, MONIKA BRATOVA, JURAJ KULTAN, MICHAL HRNCIARIK, MARKETA CERNOVSKA, PETRA ZEMANOVA, JANA KREJCI, LEONA KOUBKOVA, MAREK STASTNY and MARTIN SVATON

In Vivo September 2023, 37 (5) 2229-2236; DOI: https://doi.org/10.21873/invivo.13324
Open Access
Efficacy of Percutaneous Direct Puncture Biopsy of Malignant Lung Tumors Contacting to the Pleura
HIROSHI KODAMA, HARUYUKI TAKAKI, JUNICHI TANIGUCHI, ATSUSHI OGASAWARA, YASUKAZU KAKO, KAORU KOBAYASHI and KOICHIRO YAMAKADO

In Vivo September 2023, 37 (5) 2237-2243; DOI: https://doi.org/10.21873/invivo.13325
Open Access
Patient Preferences With Regard to Care Structures for Cervical or Vulvar Dysplasia in Certified Dysplasia Clinics in Germany
LAURA BERGER, ELKE CRAMER, CHRISTEL WEIß, MARC SÜTTERLIN and SASKIA SPAICH

In Vivo September 2023, 37 (5) 2244-2252; DOI: https://doi.org/10.21873/invivo.13326
Open Access
Influence of the Oral Health Assessment Tool Score on Survival of Patients With Esophageal Cancer
HIROSHI TAMAGAWA, AYAKO TAMAGAWA, TORU AOYAMA, ITARU HASHIMOTO, YUKIO MAEZAWA, KENTARO HARA, AYA KATO, NATSUMI KAMIYA, KAZUKI OTANI, MASAKATSU NUMATA, KEISUKE KAZAMA, JYUNYA MORITA, MIE TANABE, SHIZUNE ONUMA, HARUHIKO CHO, SHO SAWAZAKI, TAKASHI OHSHIMA, NORIO YUKAWA, KENJI MITSUDO, AYA SAITO and YASUSHI RINO

In Vivo September 2023, 37 (5) 2253-2259; DOI: https://doi.org/10.21873/invivo.13327
Open Access
Serum Albumin Affects the Time-to-treatment Failure of Alectinib: A Multicenter Retrospective Study
KENGO UMEHARA, KAORI YAMA, KEISUKE GOTO, TAKANOBU HOSHI, TOMOAKI HATAKEYAMA, MARIKO ISAJI, SHINYA TAKADA, KAYO YAMAGISHI, KOZO MINO and HIDEKI SATO

In Vivo September 2023, 37 (5) 2260-2267; DOI: https://doi.org/10.21873/invivo.13328
Open Access
Durable Stable Disease by Atezolizumab/Bevacizumab Can Provide Long-term Survival of Patients With Hepatocellular Carcinoma Lung Metastases
TOSHIHIKO MOTOHARA, KENSUKE YAMAMURA, HIDEAKI MIYAMOTO, SHIGENORI UENO, HIROSHI TAKENO, YASUNORI NAGAYAMA, ERI ODA, RYUICHI KARASHIMA, NOBUYUKI OZAKI, TATSUNORI MIYATA, KOSUKE MIMA, HIROHISA OKABE, TAKATOSHI ISIKO and TORU BEPPU

In Vivo September 2023, 37 (5) 2268-2275; DOI: https://doi.org/10.21873/invivo.13329
Open Access
Incidence of Pulmonary and Respiratory Conditions in Gaucher Disease from 2000 to 2020: A Multi-institutional Cohort Study
YU-NAN HUANG, JING-YANG HUANG, WEN-LING LIAO, SHANG-LUN CHIANG, KAI-WEN LIU, DA-TIAN BAU, CHUNG-HSING WANG and PEN-HUA SU

In Vivo September 2023, 37 (5) 2276-2283; DOI: https://doi.org/10.21873/invivo.13330
Open Access
Assessing the Risk of Stroke in the Elderly in the Context of Long-COVID, Followed Through the Lens of Family Medicine
ANDRADA FLORINA MOLDOVAN, IOANA MOGA, TITUS MOGA, EVELIN CLAUDIA GHITEA, KATALIN BABES and TIMEA CLAUDIA GHITEA

In Vivo September 2023, 37 (5) 2284-2295; DOI: https://doi.org/10.21873/invivo.13331
Open Access
Clinicopathological Significance of DUB3 Expression in Non-small Cell Lung Cancer and Relationship Between DUB3 Expression and LATS1 Expression
SI-HYONG JANG, HYUN DEUK CHO, JI-HYE LEE and MEE-HYE OH

In Vivo September 2023, 37 (5) 2296-2305; DOI: https://doi.org/10.21873/invivo.13332
Open Access
Plasma Circulating Cell-free DNA in Advanced Hepatocellular Carcinoma Patients Treated With Radiation Therapy
DONG-YUN KIM, EUN-HAE CHO, JAE SIK KIM, EUI KYU CHIE and HYUN-CHEOL KANG

In Vivo September 2023, 37 (5) 2306-2313; DOI: https://doi.org/10.21873/invivo.13333
Open Access
Serum Testosterone Is Associated With the Severity of COVID-19
EMA SUZUKI, KOJI KURONUMA, RYOSEI MURAI, YOSHIHIRO FUJIYA, ATSUSHI SAITO, HIROFUMI CHIBA and SATOSHI TAKAHASHI

In Vivo September 2023, 37 (5) 2314-2319; DOI: https://doi.org/10.21873/invivo.13334
Open Access
Clinical Outcomes of Radiotherapy for Stage 1 Glottic Carcinoma: Comparing Accelerated Hyperfractionation and Once-daily Fractionation
MASASHI ENDO, YUKIKO FUKUDA, KOHEI OKADA, KAZUNARI OGAWA, MICHIKO NAKAMURA, SATORU TAKAHASHI, ERI MURAKAMI, CHIAKI SHIBAYAMA, MASAHIRO KAWAHARA, KEIKO AKAHANE, RYUTARO ONAGA, TAKAFUMI NAGATOMO, TAKEHARU KANAZAWA, HIROSHI NISHINO, HARUSHI MORI and KATSUYUKI SHIRAI

In Vivo September 2023, 37 (5) 2320-2326; DOI: https://doi.org/10.21873/invivo.13335
Open Access
Relationship Between SGLT2 Inhibitors and Hemoglobin Levels: A Retrospective Observational Study
YUKI YOSHIDA, KOHEI TAKAHASHI, RYU HASHIMOTO, TOMONORI OYA and JUNYA SATO

In Vivo September 2023, 37 (5) 2327-2333; DOI: https://doi.org/10.21873/invivo.13336
Open Access
L1CAM Is Not a Predictive Factor in Early-stage Squamous-cell Cervical Cancer
MARTINA ROMANOVÁ, VLADIMÍR ŽIDLÍK, VERONIKA JAVŮRKOVÁ, ADELA KONDÉ, ONDŘEJ ŠIMETKA and JAROSLAV KLÁT

In Vivo September 2023, 37 (5) 2334-2339; DOI: https://doi.org/10.21873/invivo.13337
Open Access
Association Between Thyroid Radiation Dose and Hypothyroidism in Breast Cancer Patients Undergoing Volumetric Modulated Arc Therapy for Regional Nodal Irradiation
HYEON KANG KOH, YOUNGHEE PARK, TAERYOOL KOO, KWANG-HO CHEONG, ME YEON LEE, HAE JIN PARK, KYOUNG JU KIM, SOAH PARK, TAEJIN HAN, SEI-KWON KANG, BORAM HA, JAI-WOONG YOON, ME YOUNG KIM and HOONSIK BAE

In Vivo September 2023, 37 (5) 2340-2346; DOI: https://doi.org/10.21873/invivo.13338
Open Access
A Model for Gastric Cancer Risk Prediction Based on MUC1 Polymorphisms and Health-risk Behaviors in a Vietnamese Population
NGOC-LAN THI NGUYEN, NGOC DUNG THI DANG, QUY VAN VU, ANH KIM DANG and THANH-VAN TA

In Vivo September 2023, 37 (5) 2347-2356; DOI: https://doi.org/10.21873/invivo.13339
Open Access
Smoking Status at Time of Diagnosis Affects the Efficacy of Anti-PD-1/L1 Therapy in Patients With Advanced NSCLC
KYU YEAN KIM, JEONG UK LIM, HYE SEON KANG, JU SANG KIM, SUNG KYOUNG KIM, SEUNG JOON KIM, SANG HAAK LEE and CHANG DONG YEO

In Vivo September 2023, 37 (5) 2357-2364; DOI: https://doi.org/10.21873/invivo.13340
Open Access
Predictors of Outcomes in Patients With Clinically Lymph Node Positive Prostate Cancer After Definitive Radiotherapy
TAE HYUN KIM, DONG-YUN KIM and JAE-SUNG KIM

In Vivo September 2023, 37 (5) 2365-2370; DOI: https://doi.org/10.21873/invivo.13341
Open Access
Highlighting the Advantages and Benefits of Non-NSAID Treatment After Total Knee Arthroplasty: A Cross-sectional Study
GELU FLORIN MURVAI, CALIN TUDOR HOZAN, CALIN MAGHERU, GHEORGHE SZILAGYI, MADALIN BULZAN, VIORELA ROMINA MURVAI, SIMONA CAVALU and TIMEA CLAUDIA GHITEA

In Vivo September 2023, 37 (5) 2371-2380; DOI: https://doi.org/10.21873/invivo.13342
Open Access
COVID-19-related Floating Thrombus in the Ascending Aorta – A Case Report
ROXANA CARMEN GEANA, REZA NAYYERANI, RAZVAN PETRU DRAGULESCU, IOANA MARINICA, NICOLAE BACALBASA, IRINA BALESCU, CAMELIA DIACONU, VLAD ANTON ILIESCU, VICTOR CAUNI and OVIDIU STIRU

In Vivo September 2023, 37 (5) 2381-2386; DOI: https://doi.org/10.21873/invivo.13343
Open Access
Age, Sex, Metabolic and Pharmacologic Factors May Predict Nonresponse Status to Rheumatoid Arthritis Therapies
LILIANA BORDEAN, MONICA CHIS, ANCA MARIA CIMPEAN, ALINA CRISTINA BARB, ANDREI ALEXANDRU COSMA, MIHAELA PASCA FENESAN, OVIDIU SIMION COTOI, LAURA NICOLESCU, CRISTIAN MIRCEA NICOLESCU and CLAUDIU AVRAM

In Vivo September 2023, 37 (5) 2387-2401; DOI: https://doi.org/10.21873/invivo.13344

Main menu

User menu

Search

Table of Contents

Reviews

Experimental Studies

Clinical Studies

In this issue

Issue highlights

Jump to